TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Enorama Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
122
|
615
|
1,079 |
| Financial expenses |
323
|
188
|
78 |
| Earnings before taxes |
-4,021
|
-3,777
|
-2,713 |
| EBITDA |
-3,477
|
-3,409
|
-2,499 |
| Total assets |
3,099
|
4,378
|
4,980 |
| Current assets |
1,168
|
1,056
|
2,191 |
| Current liabilities |
921
|
1,117
|
1,142 |
| Equity capital |
1,761
|
2,833
|
2,088 |
| - share capital |
576
|
131
|
117 |
| Employees (average) |
5
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
56.8%
|
64.7%
|
41.9% |
| Turnover per employee |
24
|
68
|
108 |
| Profit as a percentage of turnover |
-3295.9%
|
-614.1%
|
-251.4% |
| Return on assets (ROA) |
-119.3%
|
-82.0%
|
-52.9% |
| Current ratio |
126.8%
|
94.5%
|
191.9% |
| Return on equity (ROE) |
-228.3%
|
-133.3%
|
-129.9% |
| Change turnover |
-495
|
-376
|
869 |
| Change turnover % |
-80%
|
-38% | |
| Chg. No. of employees |
-4
|
-1
|
3 |
| Chg. No. of employees % |
-44%
|
-10% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.